(Q46108173)

English

A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study

scientific article published in January 2001

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

phase II clinical trial

0 references

gynecologic oncology

1 reference

based on heuristic

inferred from title

author name string

Plaxe SC

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

Blessing JA

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

Lucci JA

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

Hurteau JA

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

19

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

77-80

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11291835

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006469006460

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/11291835

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46108173&oldid=2207639734"